In several states like New York, Minnesota, Utah, and even Texas, non-white citizens are receiving priority for scarce monoclonal antibody treatments and Covid oral antiviral pills, regardless of their age or underlying conditions, thanks to Marxist health-equity policies that have been implemented by the local governments.
This ‘rationing based on race’ policy has sparked intense backlash against the states which have implemented them, but the idea did not start within local health departments – the destructive scheme actually came directly from the Food and Drug Administration (FDA), according to the agency’s own documents.
The FDA’s emergency use authorizations for monoclonal antibodies and oral antivirals specify that the treatments have only been authorized for “high risk” patients. The agency included guidelines on what factors would qualify a patient to receive the therapeutics, and unsurprisingly, one of the main determinations was their race.
Even though the FDA’s guidelines are nonbinding and unenforceable, they have been used by the local state governments as justification for implementing the racist policy.
Racism – FDA approved – because, it’s for your health.
The FDA “fact sheet” for Sotrovimab, the only monoclonal antibody effective against the Omicron variant, states that ‘race or ethnicity’ can ‘place individual patients at high risk for progression to severe COVID-19.’
The fact sheet for Paxlovid, Pfizer’s new antiviral pill, uses the Centers for Disease Control and Prevention’s definition of ‘high risk,‘ which states that ‘systemic health and social inequities’ have put minorities ‘at increased risk of getting sick and dying from COVID-19.’
The guidance sheets are nonbinding and do not require clinicians to racially allocate the drugs. But states have nonetheless relied on them to justify race-based triage.
“The FDA has acknowledged that in addition to certain underlying health conditions, race and ethnicity ‘may also place individual patients at high risk for progression to severe COVID-19,’ Minnesota’s plan reads. ‘FDA’s acknowledgment means that race and ethnicity alone, apart from other underlying health conditions, may be considered in determining eligibility for [monoclonal antibodies].’”
How is this even legal in America?
The FDA declined to comment on either state’s plan, saying only that “there are no limitations on the authorizations that would restrict their use in individuals based on race,” according to The Washington Free Beacon.
Almost TWO FULL YEARS since ‘fifteen days to slow the spread,’ America still has not been allowed to put this manufactured pandemic in the rearview mirror.
Despite promising that he would ‘shut down the virus instead of ‘shutting down the country,’ Brandon and his completely incompetent regime have overseen more deaths than there were in 2020, new lockdowns, tyrannical mandates, and several new ‘variants’ that have restarted the proverbial pandemic clock for the public health regime.
Keep in mind, this is all with a vaccine that has been available throughout Brandon’s entire fraudulent presidency.
The shortage of treatments, which is being driven by the FDA’s refusal to approve effective drugs like Ivermectin for use on Covid-19, has been compounded by Brandon’s bonehead decision to cut off the procurement of several treatments like monoclonal antibodies.
Because of the limited availability of Covid treatments, the Federal government has been rationing the supply as it distributes to the individual states, which has caused some areas to experience major shortages, especially as the highly transmissible, yet common-cold-like Omicron variant continues to spread.
You would think that after two full years, we as a nation – one that landed a man on the moon from concept to completion in less than 10 years (and that was before the pocket calculator had been invented) – would have this mild flu-like virus somewhat under control by now, but thanks to the Brandon Administration, there aren’t even enough early treatment drugs to go around.
So naturally, the woke Marxists are rationing potentially life-saving treatments based on skin color.
How far we have fallen.